title: [Pharmacogenomics of the immunosuppressive agents].
authors.affiliation: Institute of Rheumatology, Tokyo Women's Medical University.
authors.forename: Atsuo
authors.initials: A
authors.lastname: Taniguchi
authors.forename: Wako
authors.initials: W
authors.lastname: Urano
authors.forename: Eiichi
authors.initials: E
authors.lastname: Tanaka
authors.forename: Yutaka
authors.initials: Y
authors.lastname: Kitamura
authors.forename: Masayuki
authors.initials: M
authors.lastname: Saito
authors.forename: Hideto
authors.initials: H
authors.lastname: Akama
authors.forename: Hishashi
authors.initials: H
authors.lastname: Yamanak
authors.forename: Terunobu
authors.initials: T
authors.lastname: Saito
authors.forename: Naoyuki
authors.initials: N
authors.lastname: Kamatani
mesh_terms: D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000235:genetics; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use*; D042965:Methylenetetrahydrofolate Reductase (NADPH2); D008875:Middle Aged; D000587:Oxidoreductases Acting on CH-NH Group Donors / Q000235:genetics*
chemical_list: D018501:Antirheumatic Agents; D007166:Immunosuppressive Agents; D000587:Oxidoreductases Acting on CH-NH Group Donors; D042965:Methylenetetrahydrofolate Reductase (NADPH2); D008727:Methotrexate